Table 1.
Organ/tissue
|
Positive regulation
|
Negative regulation
|
Liver | ↑ ApoAI; ↑ ApoAII; ↑ ApoAV | ↓ Apoptosis |
↑ Cholesterol catabolism | ↓ HL | |
↑ FA oxidation and activation | ↓ Inflammation | |
↑ Fatty acid oxidation genes | ↓ Oxidative stress | |
↑ FATP; ↑ FAT/CD3 | ↓ Proteolysis of SREBF1 | |
↑ Gluconeogenesis and glycolysis | ↓ SREBF2 | |
↑ Insig1 | ||
↑ Ketogenesis | ||
↑ Lipogenesis | ||
↑ LPL and triglyserides clearance | ||
Skeletal muscle | ↑ FA oxidation gene | ↓ Glucose intolerance |
↑ FA oxidation | ||
↑ Insulin sensitivity | ||
Cardiac muscle | ↑ AT2 receptor | ↓ AT1 receptor |
↑ FA uptake | ↓ Cardiac hypertrophy and inflammation | |
↑ FA oxidation | ↓ Genes for glucose uptake and oxidation | |
↓ ED-1 (CD68) expression | ||
↓ NF-κB activity | ||
↓ VCAM-1, ICAM-1 | ||
↓ Platelet and endothelial cell adhesion | ||
Plasma | ↑ HDL | ↓ ApoC3 |
↑ RCT | ↓ Dyslipidemia | |
↓ Inflammation | ||
↓ IFN-γ | ||
↓ TNFα | ||
↓ sdLDL | ||
↓ VLDL-triglyserides |
Apo: Apoprotein; AT1: Endothelin-1 receptor; AT2: Endothelin-2 receptor; IFN-γ: Interferon gamma; FA: Fatty acid; FATP: Fatty acid transport protein; ICAM-1: Insig-1: Insulin induced gene-1; LPL: Lipoprotein lipase; RCT: Reverse cholesterol transport; sdLDL: Small-dense LDL; VCAM-1: Vascular cell adhesion molecules-1; TNFα: Tumor necrosis factor-alpha.